Inspiration Health - Board Change

Inspiration Healthcare

06/06/2025 07:00

RNS Number : 7090L

Inspiration Healthcare Group PLC

06 June 2025

 

 

6 June 2025                                                                            

Inspiration Healthcare Group plc

 

("Inspiration Healthcare", the "Company" or the "Group")

 

Board Change

 

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company pioneering best-in-class, specialist neonatal intensive care medical devices, announces that Neil Campbell, non-executive director, has informed the Board that he will not be seeking re-election at the Company's 2025 Annual General Meeting and will formally step down from the Board on 24 July 2025 at the end of the Board meeting scheduled to be held on that day. The Company does not intend to replace this position but will instead keep the composition of the Board under review.

 

Roy Davis, Chair, said:

 

"On behalf of myself and the Board, I would like to thank Neil for his outstanding commitment and invaluable contribution to the Company over the many years since its founding. He has taken the Company from inception to the position it is today and ensured the smooth transition of leadership since standing down as CEO last year. We wish Neil every success in his future endeavours."

 

Neil Campbell, said:

 

"Having stepped down from being CEO last summer it has been a privilege to have served on the Board as a non-executive director and help with the transition to a new management team. However, with a new CEO in place and the company moving forward, it is the right time for me to move on to new challenges and support the Company as a shareholder. I would like to thank Roy Davis, Chair, for giving me the opportunity to be a non-executive director and wish the Company the very best for the future."

 

 

For further information, please contact:

 

Inspiration Healthcare Group plc
Tel: +44 (0)330 175 0000
Raffi Stepanian, Chief Executive Officer
Alan Olby, Chief Financial Officer
Panmure Liberum (Nominated Adviser & Broker)
Tel: +44 (0)20 3100 2000
Emma Earl
Will Goode
Walbrook PR Ltd (Media and Investor Relations)
Tel: +44 (0)20 7933 8780 orinspirationhealthcare@walbrookpr.com
Anna Dunphy
Mob: +44 (0) 7876 741 001


 

About Inspiration Healthcare

 

Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering medical technology. Based in the UK, the Company specialises in neonatal intensive care medical devices, which are addressing a critical need to help to save the lives and improve the outcomes of patients, starting with the very first breaths of life.

 

The Company has a broad portfolio of its own products and complementary distributed products, for use in neonatal intensive care designed to support even the most premature babies throughout their hospital stay. Its own branded products range from highly sophisticated capital equipment such as ventilators for life support through to single-use disposables.

 

The Company sells its products directly to hospitals and healthcare providers in the UK and Ireland, where it also distributes a range of advanced medical technologies for infusion therapy.  In the rest of the world the Company has an established network of distribution partners around the world giving access to more than 75 countries.

 

The Company operates in the UK from its Manufacturing and Technology Centre in Croydon, South London, and in the USA from its facility in Melbourne, Florida.

 

Further information on Inspiration Healthcare can be found at www.inspirationhealthcaregroup.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
BOAFAMBTMTJMTIA